Stocklytics Platform
Asset logo for symbol REPL
Replimune Group
REPL31
$14.93arrow_drop_up34.75%$3.84
Asset logo for symbol REPL
REPL31

$14.93

arrow_drop_up34.75%

Performance History

Chart placeholder
Key Stats
Open$13.68
Prev. Close$11.05
EPS-3.04
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range12.00
16.48
52 Week Range4.92
16.48
Ratios
Revenue-
EBITDA Margin %-
EPS-3.04

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Replimune Group (REPL)

Replimune Group Inc (REPL) is a biotechnology company focused on developing oncolytic immunotherapies to treat cancer. The company's lead product candidate, RP1, is designed to selectively replicate within tumors and induce a strong immune response against cancer cells. Replimune Group Inc aims to harness the power of the immune system to fight cancer, potentially offering a new treatment option for patients.
The stock price history of Replimune Group Inc has shown volatility since its initial public offering (IPO). Investors should note that the stock price can be influenced by various factors, including clinical trial results, regulatory approvals, and market conditions. It is important to conduct thorough research and analysis before making any investment decisions.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Philip Astley-Sparke F.S.A., FSA
Headquarters
Woburn
Employees
284
Exchange
NASDAQ
add Replimune Group  to watchlist

Keep an eye on Replimune Group

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Replimune Group 's (REPL) price per share?

The current price per share for Replimune Group (REPL) is $14.93. The stock has seen a price change of $3.84 recently, indicating a 34.75% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Replimune Group (REPL)?

For Replimune Group (REPL), the 52-week high is $16.48, which is 10.41% from the current price. The 52-week low is $4.92, the current price is 203.46% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Replimune Group (REPL) a growth stock?

Replimune Group (REPL) has shown an average price growth of -4.13% over the past three years. It has received a score of 28 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Replimune Group as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Replimune Group (REPL) stock price performance year to date (YTD)?

As of the latest data, Replimune Group (REPL) has a year-to-date price change of 72.2%. Over the past month, the stock has experienced a price change of 24.73%. Over the last three months, the change has been 47.24%. Over the past six months, the figure is 151.77%. Looking at a longer horizon, the five-year price change stands at 11.33%.
help

Is Replimune Group (REPL) a profitable company?

Replimune Group (REPL) has a net income of -$215.79M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$234.77M. Furthermore, the EBITDA is -$226.71M.
help

What is the market capitalization of Replimune Group (REPL)?

Replimune Group (REPL) has a market capitalization of $1.02B. The average daily trading volume is 15.48, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level